Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001172661-25-001097·BioAge Labs, Inc.
Schedule 13G ownership disclosure
BioAge Labs Inc
Common Stock, par value $0.00001 per share · CUSIP: 09077V100
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Cormorant Asset Management, LP
Shares: 2,629,529.00 · Class: 7.34%
- Bihua Chen
Shares: 2,629,529.00 · Class: 7.34%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-001097
- Form type
- SCHEDULE 13G
- Filer
- BioAge Labs, Inc.
- CIK
- CIK 1709941
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership